Name: BRIEFING ON CAR-T CELLS TRIALS - 2020
SKU: 9211
Availability: InStock

BRIEFING ON CAR-T CELLS TRIALS – 2020

CAR-T cells therapies are at the forefront of innovation in oncology.
The second edition of our “BRIEFING ON CAR-T CELLS TRIALS”
provides you a suitable tool to explore the latest trials
in this hot and rapidly evolving field.

At least 5 reasons to buy this updated report

■ More than 140 new clinical trials registered between 01/01/2018 and 12/01/2019

■ For each clinical trial mentioned, a novel format enriched by relevant contextualisation and informations selected by our experts

■ All products are described

■ A time saving and dedicated tool that provides an accurate overview of the latest developements in this rapidly evolving field

■ An affordable price for a synthetic and efficient tool for retrieving or extracting the valuable information you need

Click to get sample pages

Download the Order Form

BRIEFING ON CAR-T CELLS TRIALS – 2020

CAR-T cells therapies are at the forefront of innovation in oncology.
The second edition of our “BRIEFING ON CAR-T CELLS TRIALS”
provides you a suitable tool to explore the latest trials
in this hot and rapidly evolving field.

At least 5 reasons to buy this updated report

■ More than 140 new clinical trials registered between 01/01/2018 and 12/01/2019

■ For each clinical trial mentioned, a novel format enriched by relevant contextualisation and informations selected by our experts

■ All products are described

■ A time saving and dedicated tool that provides an accurate overview of the latest developements in this rapidly evolving field

■ An affordable price for a synthetic and efficient tool for retrieving or extracting the valuable information you need

Download the Order Form

BRIEFING ON CAR-T CELLS TRIALS – 2020

CAR-T cells therapies are at the forefront of innovation in oncology. “BRIEFING ON CART-T CELLS TRIALS” provides you with an accurate overview to explore the latest trials in this hot and rapidly evolging field.

More than 20 diseases, mainly hematological cancers and solid tumors

47 trials and 33 sponsors in Asia, Europa and USA

More than 12 antigens targeted by clinical trials registered on Clinicaltrials.gov from 01/01/2017 to 01/10/2018

Breakdown by disease of CAR-T cell trials registered on Clinicaltrials.gov from 01/01/2017 to 01/10/2018:
Acute Lymphoblastic Leukemia (ALL), B Acute Lymphoblastic Leukemia (B – ALL), Acute Myeloid Leukemia, B-cell Lymphoma, Diffuse Large B-cell Lymphoma, Blastic Plasmacytoid Dendritic Cell Neoplasm, Chronic Lymphocytic Leukemia (CLL,) Colon Cancer Liver Metastasis, EGFR-positive Colorectal Cance,r Hematological Malignancies, Leukemias, Lymphomas Hepatocellular Carcinoma, Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma Lymphoid Cancer, Multiple Myeloma ,Non Hodgkin Lymphoma, Pancreatic Cancer, Plasma Cell Myeloma, Solid Tumors, Systemic Lupus Erythematosus (SLE)

BRIEFING ON CAR-T CELLS TRIALS – 2020

Studies

CAR-T cells therapies are at the forefront of innovation in oncology.
The second edition of our “BRIEFING ON CAR-T CELLS TRIALS”
provides you a suitable tool to explore the latest trials
in this hot and rapidly evolving field.

At least 5 reasons to buy this updated report